BioXcel Holdings, Inc.

Other

US·SEC (Form 4)

BioXcel Therapeutics, Inc.

0

Total declarations

0

Company

—

▲ Purchases (0 ops.)

€24m

▼ Sales (2 ops.)

Browse the full record of transactions filed by BioXcel Holdings, Inc.. Director active across 1 companies, notably BioXcel Therapeutics, Inc.. Cumulatively, 2 disclosures have been recorded. Total volume traded: €24.5m. The latest transaction was disclosed on 25 June 2021 — Cession. Regulator: SEC (Form 4). All data is openly available.

Declarations2 total

Executives▼SaleBBioXcel Therapeutics, Inc.29SEC

B

BioXcel Holdings, Inc.

€12m473,250 shares@ €25.8403100.0% of flow

Common Stock

SEC:0001104659-21-086943·25 Jun 2021

SEC ↗

Executives▼SaleBBioXcel Therapeutics, Inc.◆Signal · 47SEC

B

BioXcel Holdings, Inc.

€12m473,250 shares@ €25.840339.62% mcap50.0% of flow